Yahoo! Finance: Top Stories

Argenx Secures EC Approval for Subcutaneous VYVGART in CIDP Treatment

Jun 24, 2025 - 18:06
 0
Argenx Secures EC Approval for Subcutaneous VYVGART in CIDP Treatment
Read More

Tags:

Previous Article

Madrigal Pharmaceuticals Closer to EU Approval for First MASH Treatment, Rezdiffra

Next Article

Amazon Rival, Cathie Wood Stock Soars 44%; Crypto Outlook Lends Wings

Related Posts

Nissan’s global sales fall by 7% in April

Nissan’s global sales fall by 7% in April

May 31, 2025  0

Xcel Energy Stock Powers Ahead With A Bright Future

Xcel Energy Stock Powers Ahead With A Bright Future

May 30, 2025  0

Dollar General Stock Rises on Earnings Beat. Here’s What We Know.

Dollar General Stock Rises on Earnings Beat. Here’s Wha...

Jun 3, 2025  0